Clinical Trial Update: Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization [NA]

View source ↗

Summary

A completed clinical trial update investigating aqueous VEGF levels in type 3 neovascularization associated with age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: University of Molise | Conditions: Age-related Macular Degeneration | NA | Status: COMPLETED